Corey D Cicci, A. Weiss, C. Dang, M. Stanton, R. Feldman
{"title":"四因子凝血酶原浓缩物给药的时间和剂量对华法林相关颅内出血结局的影响","authors":"Corey D Cicci, A. Weiss, C. Dang, M. Stanton, R. Feldman","doi":"10.1002/phar.2680","DOIUrl":null,"url":null,"abstract":"The objective of this study was to evaluate clinical outcomes associated with time to administration and dose of four‐factor prothrombin complex concentrate (4F‐PCC) in patients with ICH on warfarin.","PeriodicalId":19812,"journal":{"name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage\",\"authors\":\"Corey D Cicci, A. Weiss, C. Dang, M. Stanton, R. Feldman\",\"doi\":\"10.1002/phar.2680\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The objective of this study was to evaluate clinical outcomes associated with time to administration and dose of four‐factor prothrombin complex concentrate (4F‐PCC) in patients with ICH on warfarin.\",\"PeriodicalId\":19812,\"journal\":{\"name\":\"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/phar.2680\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/phar.2680","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage
The objective of this study was to evaluate clinical outcomes associated with time to administration and dose of four‐factor prothrombin complex concentrate (4F‐PCC) in patients with ICH on warfarin.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
